Objectives: To develop a predictive nomogram for chronic kidney disease-free survival probability in the long term after partial nephrectomy. Methods: A retrospective analysis was carried out of 698 patients with T1 renal tumors undergoing partial nephrectomy at a tertiary academic institution. A multivariable Cox regression analysis was carried out based on parameters proven to have an impact on postoperative renal function. Patients with incomplete data, <12 months follow up and preoperative chronic kidney disease stage III or greater were excluded. The study end-points were to identify independent risk factors for new-onset chronic kidney disease development, as well as to construct a predictive model for chronic kidney disease-free survival probability after partial nephrectomy. Results: The median age was 52 years, median tumor size was 2.5 cm and mean warm ischemia time was 28 min. A total of 91 patients (13.1%) developed new-onset chronic kidney disease at a median follow up of 60 months. The chronic kidney diseasefree survival rates at 1, 3, 5 and 10 year were 97.1%, 94.4%, 85.3% and 70.6%, respectively. On multivariable Cox regression analysis, age (1.041, P = 0.001), male sex (hazard ratio 1.653, P < 0.001), diabetes mellitus (hazard ratio 1.921, P = 0.046), tumor size (hazard ratio 1.331, P < 0.001) and preoperative estimated glomerular filtration rate (hazard ratio 0.937, P < 0.001) were independent predictors for new-onset chronic kidney disease. The C-index for chronic kidney disease-free survival was 0.853 (95% confidence interval 0.815-0.895). Conclusion: We developed a novel nomogram for predicting the 5-year chronic kidney disease-free survival probability after on-clamp partial nephrectomy. This model might have an important role in partial nephrectomy decision-making and follow-up plan after surgery. External validation of our nomogram in a larger cohort of patients should be considered.
Introduction
PN has been recommended for the treatment of T1 renal tumors whenever technically feasible. 1 CKD stage III, which is defined as an eGFR level of <60 mL/min/1.73 m 2 , is associated with a higher risk for cardiovascular diseases, prolonged hospitalization and mortality. 2 PN has been proved to be associated with a lower postoperative risk of new-onset CKD, 3 as well as protecting against end-stage renal disease and the need for dialysis relative to RN. 4 However, despite the protective effect of PN on renal function, CKD stage III or greater will develop postoperatively in approximately one-third of patients with preoperative eGFR >60 mL/min/1.73 m 2 . 5 In 2006, Sorbellini et al. developed a nomogram to predict renal insufficiency after RN or PN. 6 A small number of patients underwent PN (n = 161); concomitant RN and PN cases in the same nomogram, short follow-up period (median of 21 months), and using serum creatinine level in the renal function assessment were the main limitations of their nomogram. To our knowledge, there is no available model for predicting CKD-free survival after PN. Thus, we aimed to develop a predictive nomogram among patients who underwent PN in our tertiary academic center on the long-term follow up.
Methods

Ethical standards
The present study was carried out at Yonsei Severance Hospital and data were extracted from our prospectively maintained database after institutional ethical committee review board approval (IRB number: 2014-0091-001).
Inclusion and exclusion criteria
From 2003 to 2012, 698 patients who underwent PN and met our inclusion criteria were included in the current study. Inclusion criteria were: patients with T1 localized renal mass, preoperative eGFR ≥60 mL/min/1.73 m 2 , normal contralateral kidney, solitary renal mass, minimum 12 months of follow up, no previous kidney surgery (ipsilateral or contralateral) and no history of inflammatory renal condition, kidney cancer or urothelial carcinoma. Exclusion criteria were conversion to RN (n = 18) and incomplete nomogram data (n = 147).
Surgical technique
Patients underwent open, laparoscopic and robot-assisted PN. Our PN surgical techniques have been previously discussed. 7, 8 The choice of surgical approach was based on the surgeon's experience and patient's preference.
Clinical variables
Patients' demographic characteristics and perioperative data were extracted including: age, sex, BMI, the ASA score, DM, HTN, CAD, preoperative eGFR, preoperative CKD stage, RENAL nephrometry score, tumor size, clinical stage, tumor histopathology, clamp type, WIT and PN technique.
Nomogram construction
We incorporated readily available clinical parameters to construct our nomogram through a literature review of PN studies that evaluated the most important predictors of poor long-term renal function and/or CKD development. [9] [10] [11] [12] [13] [14] [15] [16] [17] Preoperative proteinuria was defined when the result of dipstick urinalysis test was ≥1+. Furthermore, to eliminate any possible effect of the different PN techniques in the present study, we used Cox regression analysis. Given the wide timespan of the study (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) , year of diagnosis was included into the multivariable analysis to account for potential differences in preoperative, intraoperative and follow-up factors.
Renal function follow up
Regarding the renal function evaluation, eGFR was calculated using the Modification of Diet in Renal Disease formula. After surgery, eGFR was measured in the same laboratory preoperatively and on the first day; first week; and first, third, sixth and the 12th months, then yearly. The latest eGFR was defined as the value of eGFR at the last follow up. Patients who had new-onset CKD upgrading into stage III or greater (i.e. eGFR <60 mL/min/1.73 m 2 for at least two measurements) were analyzed.
Outcomes measurement
The study end-points were to identify independent risk factors for new-onset CKD development, as well as to construct a predictive model for CKD-free survival probability after PN on the long-term follow up.
Statistical analysis
Descriptive statistics were used to summarize baseline characteristics, treatments and outcomes. Data are expressed as mean AE SD for continuous variables and frequency (percentage) for categorical variables.
Univariate Cox proportional hazards regression analysis was used to identify the significant risk factors among our data that predict new-onset CKD development after PN. Variables for which the P-value in univariable analysis was <0.05 were included in the multivariable Cox proportional hazards regression analyses to develop the predictive model. Survival curves were estimated with using the Kaplan-Meier method.
The nomogram was constructed to provide visual explanation for predicted probabilities of a survival outcome, as obtained by the statistical predictive model. The point system was carried out in scoring based on the weighted relative importance of individual risk factors, and individual 1-, 3-, 5-and 10-year disease-free survival probability.
Internal validation of the models was carried out by the bootstrapping (200 resampling) method, to examine how well the model-based predicted probabilities of CKD-free survival agreed with the actual probabilities for the censored observations. In addition, the C-index was calculated for the nomogram to test its predictive power using the concept of concordance.
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P-values of <0.05 were considered statistically significant. All statistical analyses were carried out using SAS (version 9.1; SAS Institute, Cary, NC, USA) and R software (version 3.2.4; R Foundation for Statistical Computing, Vienna, Austria, http://www.r-project.org), with an optional package installed, called rms.
Results
A total of 688 patients were included in the present study and underwent either open PN (n = 239), laparoscopic PN (n = 94) or robotic PN (n = 355). The median follow-up duration was 60 months (IQR 44-73 months). Almost all patients had on-clamp PN 98.6%, whereas 1.4% underwent Table 1 .
Univariable analyses of the Cox proportional hazards model showed that age at surgery (P < 0.001), male patient (P = 0.001), ASA score ≥2 (P < 0.008), DM (P = 0.001), HTN (P < 0.001), clinical tumor size (P < 0.001), RENAL nephrometry score (P = 0.003) and preoperative eGFR (P < 0.001) were potential risk factors associated with newonset CKD development. Whereas on multivariable analyses, increasing age (HR 1.041, 95% CI 1.016-1.067, P = 0.001), male patient (HR 1.653, 95% CI 1.083-3.118, P < 0.001), presence of DM at time of surgery (HR 1.921, 95% CI 1.012-3.645, P = 0.046), larger tumor size (HR 1.331, 95% CI 1.147-1.544, P < 0.001) and lower preoperative eGFR (HR 0.937, 95% CI 0.916-0.957, P < 0.001) were the most significant predictors (Table 2) , and were the main variables that constitute our Yonsei nomogram (Fig. 1) .
In the present cohort, the Harrell's C-statistic for predicting CKD-free survival was C-index 0.85, 95% CI 0.82-0.90. Calibration plots for the CKD-free survival probability at 1 year (Fig. 2a) , 3 years ( Fig. 2b ), 5 years ( Fig. 2c ) and 10 years ( Fig. 2d) showed good calibration, and the predictions reasonably approximated actual survival probabilities. KaplanMeier analysis demonstrated that CKD-free survival rates at 1-, 3-, 5-, and 10-year were 97.2%, 94.4%, 85.2% and 69.7%, respectively as shown in Figure 3 .
Discussion
Preservation of postoperative renal function is considered one of the main goals when carrying out PN, while maintaining the patient's safety and achieving an oncological cure. Several researchers have investigated the risk factors of postoperative renal function deterioration and/or CKD development after PN, and despite the fact that CKD is associated with a non-negligible risk of cardiovascular morbidities and mortality, there is no well-constructed nomogram to predict the risk of CKD occurrence after PN surgery. 2 In the present study, we developed a novel nomogram to estimate CKD-free survival probabilities on the long-term follow up in patients with T1 renal tumors who received PN. We found that older age, male sex, DM, larger tumor and lower preoperative eGFR were the strongest predictors of postoperative upgrading into CKD stage III or greater in patients with preoperative eGFR ≥60 mL/min/1.73 m 2 . In the present study, the overall incidence of new-onset CKD was 13.1% at 5 years' median follow up. Similarly, Jeon et al. on long-term follow up reported an incidence of CKD of 11.5% after PN. 14 When we constructed our Cox regression model, we chose the most important variables that have been previously reported and significantly affected the functional outcomes after PN. [9] [10] [11] [12] [13] [14] [15] [16] [17] In addition, we included patients with T1 renal masses according to the guideline's recommendations. 1 We excluded patients with <12 months of follow up to give sufficient time for renal function recovery and stabilization. 19 Form the robust literature data, it is clearly evident that the aging process has a negative irreversible effect on the renal function deterioration after PN surgery. [9] [10] [11] This was also confirmed in the present study, and age was found to be a strong significant predictor of new-onset CKD upgrading. The aging kidney is associated with kidney function loss due to various physiological changes, such as reduction of renal blood flow, development of tubulointerstitial fibrosis and glomerulosclerosis rendering it highly susceptible to acute kidney injury, as well as progression to CKD. 20 Another predictor of CKD progression was male sex. These results concur with the most recent US Renal Data System showing that 57.8%, 56.3% and 59.7% of patients with a new-onset end-stage renal disease, on dialysis and who received a kidney transplant were men. 21 This variability in CKD between men and women might be attributed to the difference in sex hormones, which has not yet been established. Interestingly, previous PN studies have shown that male sex was a significant predictor of postoperative renal function decline. 6, 9 Regarding patients' comorbidities, the present study showed that the presence of DM is considered a risk factor for new-onset CKD occurrence after PN surgery. Notably, DM has been labeled as a common cause of CKD, and its presence is an established risk factor for CKD in patients who underwent PN. 14, 22 Several studies have shown that increased tumor size is associated with postoperative renal function reduction after PN, which are in agreement with the present findings.
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Indeed, the volume and quality of the parenchymal volume that remained after tumor resection has been reported as an important factor affecting postoperative renal function. The resection of large tumors is greatly detrimental to the volume of parenchymal loss; in addition, larger defects brought about by a large tumor might have resulted in greater ischemized nephrons during deep and excess suturing, leading to a decline in postoperative eGFR. After PN, for each 1-cm increase in tumor size, there was a 1.8% decrease in eGFR (P = 0.013). 13 Recently, Lane et al. found that longterm renal function after PN is determined primarily by the quantity and quality of the renal parenchyma preserved and the preoperative eGFR value. 10 In the current study, lower preoperative eGFR was another independent predictor of new-onset CKD. Among those patients, 76 patients (83.3%) had preoperative CKD stage II, and 16.7% had preoperative CKD stage I. Several studies have identified that lower preoperative eGFR is a risk factor for renal function deterioration after surgery. [9] [10] [11] [12] Mukkamala et al. evaluated the long-term renal function of 480 patients undergoing minimally invasive PN, and found that lower preoperative eGFR (P < 0.001) is associated with a greater incidence of CKD progression. 12 This might be attributed to the presence of the inevitable impact of aging and medical comorbidities, which is supported by the findings of Simmons et al. showing that the kidney tissue quality, as measured by baseline eGFR, has a significant effect on the long-term renal function outcomes after surgery. 23 In general, the surgical trends have changed over time, and the choice of each surgical procedure for T1 renal tumors might be more influenced by the era itself. Recently, Patel et al. showed that PN utilization in renal surgery is on the rise compared with RN, and this rise is associated with robotic technology application. 24 Regarding the impact of the surgical approach on the functional outcomes, the present study did not find a difference between the three surgical approaches on long-term follow up. This is supported by a recent multicenter study that compared 285 patients who received OPN (n = 133), laparoscopic PN (n = 57) or robotassisted PN (n = 95). There was no significant difference in eGFR change in the short-term; that is, 1 month, after surgery between the three approaches. 25 We suggest that this equivalency between the surgical approaches will not differ in the long-term functional outcome follow up, as found in the present study. Currently, the impact of proteinuria on renal function has also been studied after PN surgery. Krane et al. reported 269 cases of robot-assisted PN with preoperative eGFR >60, out of which 57 patients (21.2%) had proteinuria. They found that preoperative proteinuria increased the risk of progression to stage III CKD. 17 More recently, Tachibana et al. assessed the impact of proteinuria on postoperative renal function after OPN in patients with a solitary kidney (n = 96). Proteinuria was present in 23 patients (24%), furthermore, lower preoperative eGFR (P < 0.0001) and positive proteinuria (P = 0.04) were independent predictors for CKD stage IV or greater progression. 18 On the contrary, proteinuria in the present study was not a predictor of CKD upstaging. We might explain the difference in results due to the lower rate of proteinuria 2.6% in the present study compared with 21.2% 17 and 24% 18 in the previous reports. In a large Korea National Health and Nutrition Examination Survey, Lee et al. studied the risk factors of proteinuria in 19 824 participants. 26 The rate of proteinuria ranged from 2.7% to 3.8%, 24 which is in agreement with the present results.
Despite WIT being considered an important factor that affects the early postoperative renal function, especially in the setting of a solitary kidney, our logistic regression analysis did not show a correlation between the length of WIT and the development of new-onset CKD on long-term follow up. 15 This might be attributed to the median WIT of 28 min in the present study, which lies in the safe zone between 20-30 min, as well as all our patients having two functioning renal units. Recently, Kallingal et al. prospectively evaluated the histopathological data in 37 patients undergoing PN and found that the kidney showed ischemic changes at a cellular level that recovered after reperfusion. Furthermore, they did not find a significant correlation between renal functional outcomes at 1 year and WIT. They concluded that clamp renal ischemia within a reasonable time frame is safe in patients with two functional kidneys. 27 Our nomogram is a representation of a large Korean cohort. Herewith, the major predictive variables that constitute this nomogram have been proven to be independent predictors of poor long-term renal functional outcomes and CKD development after PN in previous large USA and European series, as well as from other Asian cohorts (Table 3) .
We believe that this nomogram could play an important role in clinical PN practice, decision-making, patient counseling and postoperative follow-up protocols. For example, according to our nomogram, a 70-year-old diabetic man with a 5-cm renal mass and preoperative eGFR of 80 mL/min/ 1.73 m 2 would have a 5-year CKD-free survival probability of 50%. Of note, PN in this old patient with a T1b renal mass might be associated with increased blood loss and postoperative complications compared with RN. 28, 29 Furthermore, there is an increased risk of developing CKD within 5 years. 1-year CKD-free survival probability 3-year CKD-free survival probability 5-year CKD-free survival probability 10-year CKD-free survival probability
Linear Predictor
Total Points Figure 1 Yonsei nomogram predicts the CKD-free survival probability at 1, 3, 5 and 10 years after on-clamp PN. Each variable value is assigned a score on each axis, and the sum of scores "total points" is converted to a probability of observed events in the lowest scale.
According to our nomogram, the surgical decision can be discussed with the patient, and regardless of the surgery type (either PN or RN), this patient should have a stricter postoperative renal function follow up. Of note, late referral for CKD management has been found to be associated with increased morbidity and mortality. 30 Thus, optimal glycemic control, dietary habit changes, weight loss, other renoprotective regimens 31 and early co-management with specialists should be encouraged, as once the patient has progressed to CKD stage ≥3, the benefit of glycemic control on progression becomes unapparent. 32 Based on our nomogram, there might be additional choice for the use of active surveillance protocol in management of small renal masses among patients at increased risk of newonset CKD development after PN. Interestingly, active surveillance has been reported to be superior to RN and equivalent to PN for preserving renal function in patients with small renal masses. 33 The present study had some limitations. First, its retrospective design, which might carry uncontrolled bias. Second, different surgical approaches of PN surgery were included; however, none of them had a significant effect on the logistic regression model analysis. Third, although the nomogram results have been validated through bootstrapping, external validation from other larger studies and including different races are still warranted. Fourth, the median follow-up period in the present study was 60 months, thus the probability of our nomogram in predicting the CKD upstaging is more accurate in the first 5 years, and the reliability of it in predicting 10-year CKD-free survival might be weakened by the small number of patients followed up to 10 years. Fifth, the impact of preserved parenchymal volume on CKD upstaging was not evaluated due to insufficient data; however, we believe that it is correlated with the tumor size, which was included in our nomogram. Finally, the present nomogram can be used only in patients who will be scheduled for onclamp PN.
Despite these limitations, the present study had several strengths. It is the first study that provides an applicable predictive model to estimate 5-year CKD-free survival after on-clamp PN. Furthermore, as its components are preoperative characteristics, it will be of great help to predict CKD development before surgery and discuss with the patient the treatment decision from wider expectations. In addition, the present study represents large cohort data of a high tertiary academic center, and the patients were followed up for a median of 5 years; furthermore, the nomogram components are well-known predictors affecting CKD development, which should encourage its worldwide use, as well as having impressive predictive accuracy (C-index 0.85).
In conclusion, we developed a simple predictive model (Yonsei nomogram) for CKD-free survival probability after on-clamp PN in patients with T1 renal tumors and normal preoperative renal function. To the best of our knowledge, this is the first nomogram for long-term renal function after PN. Despite PN surgery, the incidence of new-onset CKD in the present study was 13.1%. Patient age, sex, DM status, tumor size and preoperative GFR were independent risk factors for its development. According to our nomogram, patients with a higher probability of developing new-onset CKD should have a stricter follow-up protocol including renoprotective measures. Further larger studies are warranted to externally validate our nomogram. 
